Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Allergan PLC (AGN)

NYSE
Currency in USD
Disclaimer
193.02
0.00(0.00%)
Real-time Data

AGN Comments

I have been watching this since before the merger news broke. and the way it has been acting and the large "dark pool" orders and the fat fingers down its acting the same way...there will be more news soon. idk what it may be another company with a bigger offer or something...I know theyll probably beat eps. and they have declared a .74 cent dividend . they also have new drugs available in the US and new trials starting . would not be surprised to see another buyout off of 200 ps or even higher.
I would be very surprised if another buyout offer came in. As for anti-trust issues, I don't see that either. No overlapping drugs. The Democrats that want to block the merger, just dislike pharma company's and this merger is a way for some of the presidential candidates to get some airtime and try to convince Ameticans this merger is a way for bug pharma to get more leverage, when all it really is, is a cost savings initiative to combine and eliminate some duplication.
news will come soon of a potential better offer. price is acting same as it was before...just wait ...
Really, really odd that this is down. There must be doubts about this going through.
Shooting to 188$
Not sure another bidder will come to the table. If PFE hadn't just paid cash for ARRY, they might have come to the party here.
oh yea put some more of my out of the money call options $30 in the money!!!
AGN $164.00 +26.57%
170$
Actually will get to 188 since that is the selling price. not sure why you're hung on 170.
 The deal is not for sure! It is scheduled for early 2020. So many of these deals do not happen. You should read the buyout more carefully. It states a 120 per share with a .81 ABBV per share add. .81 * ABBV current price per share 67.8 = 174.91. That is your best case scenario. What happens when ABBV drops to $50 before the deal. Now your looking at $160 a share.
Triangle?
Law suits are coming on their breast implants that have caused cancer
Potential buyout candidate. But probably not worth the downside risk.
$143
140.16
let it fly back...
Sheesh.! About time the rally started.  This should be in the 220's.
clouds o lot of clouds
This sell off seems overdone at this point.
what do u think about allergan?
Stock is in a downtrend, next support or target price is 133.
Any rumor about imnp and allergan..?
Buy pharma in bet for trump new medical system
Can someone advise about the allergan situation , what to do hold or sell ?
Hold bro. Do not sell.. they want them cheap. Teva deal at the end of this month..
I agree !
is it a good time to buy Allergan now ?
I think it is .... 190 strong support
Thxfor the opportunity to buy it 25% lower in order to win free 30%
My next add $250
allergen is also a good stock however beware of the stock price choose pfizer if you cant afford it
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.